Research ExplorerPublicationsThe guinea pig model in cardiac regeneration research. Curre...

The guinea pig model in cardiac regeneration research. Current tissue engineering approaches and future directions

Standard

The guinea pig model in cardiac regeneration research. Current tissue engineering approaches and future directions. / Stüdemann, Tim; Weinberger, Florian.

Advanced Technologies in Cardiovascular Bioengineering. ed. / Jianyi Zhang; Vahid Serpooshan. 1. ed. Springer International Publishing, 2022. p. 103-122.

Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research

Harvard

Stüdemann, T & Weinberger, F 2022, The guinea pig model in cardiac regeneration research. Current tissue engineering approaches and future directions. in J Zhang & V Serpooshan (eds), Advanced Technologies in Cardiovascular Bioengineering. 1 edn, Springer International Publishing, pp. 103-122. https://doi.org/10.1007/978-3-030-86140-7_7

APA

Stüdemann, T., & Weinberger, F. (2022). The guinea pig model in cardiac regeneration research. Current tissue engineering approaches and future directions. In J. Zhang, & V. Serpooshan (Eds.), Advanced Technologies in Cardiovascular Bioengineering (1 ed., pp. 103-122). Springer International Publishing. https://doi.org/10.1007/978-3-030-86140-7_7

Vancouver

Stüdemann T, Weinberger F. The guinea pig model in cardiac regeneration research. Current tissue engineering approaches and future directions. In Zhang J, Serpooshan V, editors, Advanced Technologies in Cardiovascular Bioengineering. 1 ed. Springer International Publishing. 2022. p. 103-122 https://doi.org/10.1007/978-3-030-86140-7_7

Bibtex

@inbook{1a31987bef0f4474830f1789e4aab7cd,
title = "The guinea pig model in cardiac regeneration research. Current tissue engineering approaches and future directions",
abstract = "Cardiovascular disease represents a major disease burden. Modern pharmacotherapy, in combination with interventional and surgical approaches, has substantially improved life expectancy for many patients. Yet, current therapies are not able to solve a causal problem, the loss of cardiomyocytes. Regenerative approaches with pluripotent stem cell-derived cardiomyocytes (PSC-CMs) have shown the ability to remuscularize the injured heart in various preclinical models. In this chapter, we summarize tissue engineering approaches and discuss the use of the cryoinjury guinea pig model for preclinical studies.",
author = "Tim St{\"u}demann and Florian Weinberger",
year = "2022",
month = mar,
day = "10",
doi = "10.1007/978-3-030-86140-7_7",
language = "English",
isbn = "978-3-030-86139-1",
pages = "103--122",
editor = "Jianyi Zhang and Vahid Serpooshan",
booktitle = "Advanced Technologies in Cardiovascular Bioengineering",
publisher = "Springer International Publishing",
address = "Switzerland",
edition = "1",

}

RIS

TY - CHAP

T1 - The guinea pig model in cardiac regeneration research. Current tissue engineering approaches and future directions

AU - Stüdemann, Tim

AU - Weinberger, Florian

PY - 2022/3/10

Y1 - 2022/3/10

N2 - Cardiovascular disease represents a major disease burden. Modern pharmacotherapy, in combination with interventional and surgical approaches, has substantially improved life expectancy for many patients. Yet, current therapies are not able to solve a causal problem, the loss of cardiomyocytes. Regenerative approaches with pluripotent stem cell-derived cardiomyocytes (PSC-CMs) have shown the ability to remuscularize the injured heart in various preclinical models. In this chapter, we summarize tissue engineering approaches and discuss the use of the cryoinjury guinea pig model for preclinical studies.

AB - Cardiovascular disease represents a major disease burden. Modern pharmacotherapy, in combination with interventional and surgical approaches, has substantially improved life expectancy for many patients. Yet, current therapies are not able to solve a causal problem, the loss of cardiomyocytes. Regenerative approaches with pluripotent stem cell-derived cardiomyocytes (PSC-CMs) have shown the ability to remuscularize the injured heart in various preclinical models. In this chapter, we summarize tissue engineering approaches and discuss the use of the cryoinjury guinea pig model for preclinical studies.

U2 - 10.1007/978-3-030-86140-7_7

DO - 10.1007/978-3-030-86140-7_7

M3 - SCORING: Contribution to collected editions/anthologies

SN - 978-3-030-86139-1

SP - 103

EP - 122

BT - Advanced Technologies in Cardiovascular Bioengineering

A2 - Zhang, Jianyi

A2 - Serpooshan, Vahid

PB - Springer International Publishing

ER -